EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Optimizing Benefits‐Harms of H. pylori Screen‐and‐Treat Programs Tailored to the Regional Settings

Duco T Mülder iD, Yi-Chia Lee iD, Mario Dinis-Ribeiro, Melissa McLeod, Jin Young Park iD, Iris Lansdorp-Vogelaar

Helicobacter · 2026

DOI: 10.1111/hel.70111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Helicobacter, 2026. Verfasst von Duco T Mülder und 5 weiteren Autor:innen. Beteiligte Einrichtung: Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article outlines how decision modeling can be used to optimize the cost‐effectiveness of H. pylori screen‐and‐treat programs. Decision models enable the translation of data from pilot studies into locally tailored strategies by adapting test modalities, treatment options, and the need to retest specific to the local setting. We summarize existing evidence from modeling studies, which consistently demonstrate that H. pylori screen‐and‐treat is cost‐effective across diverse populations. In addition, we discuss how decision modeling can support resource allocation, promote health equity, and guide implementation planning. Integrating H. pylori screen‐and‐treat into established preventive programs, such as colorectal cancer screening, may further increase efficiency and feasibility. The article concludes with a proposed research agenda to advance efficient H. pylori screen‐and‐treat programs across the globe.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriMass ScreeningHumansCost-Benefit AnalysisCost-Effectiveness AnalysisDecision Support Techniques

Autor:innen und Institutionen

  • Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France.
  • Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Department of Internal Medicine, College of Medicine, National Taiwan University and Departments of Medical Research and Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Gastroenterology, Porto Comprehensive Cancer Center and RISE@CI-IPO (Health Research Network), 4200-072 Porto, Portugal & MEDCIDS (Department of Community Medicine, Health Information, and Decision), Facul…
  • Department of Public Health, University of Otago, Wellington, New Zealand.

ORCID-Profile: Duco T Mülder, Yi-Chia Lee, Jin Young Park

Förderung

  • World Health Organization

Zitieren

APA

Mülder, D. T., Lee, Y. C., Dinis-Ribeiro, M., McLeod, M., Park, J. Y., & Lansdorp-Vogelaar, I. (2026). Optimizing Benefits‐Harms of H. pylori Screen‐and‐Treat Programs Tailored to the Regional Settings. Helicobacter. https://doi.org/10.1111/hel.70111

Vancouver

Mülder DT, Lee YC, Dinis-Ribeiro M, McLeod M, Park JY, Lansdorp-Vogelaar I. Optimizing Benefits‐Harms of H. pylori Screen‐and‐Treat Programs Tailored to the Regional Settings. Helicobacter. 2026. doi:10.1111/hel.70111

BibTeX
@article{Mlder2026,
  author = {Mülder, Duco T and Lee, Yi-Chia and Dinis-Ribeiro, Mario and McLeod, Melissa and Park, Jin Young and Lansdorp-Vogelaar, Iris},
  title = {Optimizing Benefits‐Harms of H. pylori Screen‐and‐Treat Programs Tailored to the Regional Settings},
  journal = {Helicobacter},
  year = {2026},
  doi = {10.1111/hel.70111}
}
Kostenlos starten →